ArticleFrontiers in immunology2026

Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis.

Nan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.